Curis (CRIS) Other Non Operating Income (2010 - 2021)
Curis' (CRIS) quarterly Other Non Operating Income came in at $890000.0 in Q2 2021, up 88900.0% YoY from N/an in Q2 2020, and up 88900.0% on a QoQ basis from $1000.0 in Q2 2020.
Curis (CRIS) Other Non Operating Income (2010 - 2021) Analysis & Trends
Curis (CRIS) has 12 years of Other Non Operating Income data on file, last reported at $890000.0 in Q2 2021.
- Quarterly Other Non Operating Income rose 88900.0% year-over-year to $890000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2022 was $890000.0 (changed 0.0% YoY) and the FY2021 annual result came in at $890000.0, up 3945.45% from the prior year.
- Other Non Operating Income advanced to $890000.0 in Q2 2021, from $1000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $890000.0 in Q2 2021 to a low of -$3.5 million in Q1 2019.
- A 5-year average of -$940000.0 and a median of -$821500.0 in 2018 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2019 — Other Non Operating Income tumbled 316.57% — and 2021, when it surged 88900.0%.
- Tracing CRIS's Other Non Operating Income over 5 years: stood at -$900000.0 in 2017, then gained by 10.67% to -$804000.0 in 2018, then slumped by 332.59% to -$3.5 million in 2019, then soared by 100.03% to $1000.0 in 2020, then surged by 88900.0% to $890000.0 in 2021.
- The last three Other Non Operating Income figures came in at $890000.0 (Q2 2021), $1000.0 (Q2 2020), and $21000.0 (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 890,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Dec 31, 2019 | -3.48 Mn |
| Jun 30, 2019 | -20,000.00 |
| Mar 31, 2019 | -3.50 Mn |
| Jun 30, 2018 | -804,000.00 |
| Mar 31, 2018 | -839,000.00 |
| Dec 31, 2017 | -900,000.00 |
| Sep 30, 2017 | -986,000.00 |
| Jun 30, 2017 | -981,000.00 |
| Mar 31, 2017 | -689,000.00 |
| Dec 31, 2016 | -571,000.00 |
| Sep 30, 2016 | -556,000.00 |
| Jun 30, 2016 | -610,000.00 |
| Mar 31, 2016 | -635,000.00 |
| Dec 31, 2015 | -215,000.00 |
| Sep 30, 2015 | -699,000.00 |
| Jun 30, 2015 | -759,000.00 |
| Mar 31, 2015 | -826,674.00 |